Xanax is a prescription medicine used to treat the symptoms of anxiety, panic disorder, and anxiety associated with depression. Xanax may be used alone or with other medications. Xanax belongs to a class of drugs called Agents, Benzodiazepines. It is not known if Xanax is safe and effective in children may cause serious side effects including: depressed mood, thoughts of suicide or hurting yourself, racing thoughts, increased energy, unusual risk-taking behavior, confusion, agitation, hostility, hallucinations, uncontrolled muscle movements, tremor, convulsions (seizure), and pounding heartbeats or fluttering in your chest help right away, if you have any of the symptoms listed above. The most common side effects of Xanax include: drowsiness, feeling tired, slurred speech, lack of balance or coordination, memory Alprazolam is a white crystalline powder, which is soluble in methanol or ethanol but which has no appreciable solubility in water at physiological pH. Each XANAX Tablet, for oral administration, contains 0.25, 0.5, 1 or 2 mg of alprazolam. XANAX Tablets, 2 mg, are multi-scored and may be divided as shown below:ems, and feeling anxious early in the 18 years of age.
The recommended starting oral dosage of XANAX for the acute treatment of patients with GAD is 0.25 mg to 0.5 administered three times daily. Depending upon the response, the dosage may be adjusted at intervals of every 3 to 4 days. The maximum recommended dosage is 4 mg daily (in divided doses). Use the lowest possible effective dose and frequently assess the need for continued treatment [see WARNINGS AND PRECAUTIONS]. Dosage In Panic Disorder The recommended starting oral dosage of XANAX for the treatment of PD is 0.5 mg three times daily. Depending on the response, the dosage may be increased at intervals of every 3 to 4 days in increments of no more than 1 mg per day. Controlled trials of XANAX in the treatment of panic disorder included dosages in the range of 1 mg to 10 mg daily. The mean dosage was approximately 5 mg to 6 mg daily. Occasional patients required as much as 10 mg per day. For patients receiving doses greater than 4 mg per day, periodic reassessment and consideration of dosage reduction is advised. In a controlled dose-response study, patients treated with doses of XANAX greater than 4 mg per day for 3 months were able to taper to 50% of their total maintenance dose without apparent loss of clinical benefit. The necessary duration of treatment for PD in patients responding to XANAX is unknown. After a period of extended freedom from panic attacks, a carefully supervised tapered discontinuation may be attempted, but there is evidence that this may often be difficult to accomplish without recurrence of symptoms and/or the manifestation of withdrawal phenomena [see DOSAGE AND ADMINISTRATION]. Discontinuation Or Dosage Reduction Of XANAX To reduce the risk of withdrawal reactions, use a gradual taper to discontinue XANAX or reduce the dosage. If a patient develops withdrawal reactions, consider pausing the taper or increasing the dosage to the previous tapered dosage level. In a controlled discontinuation study of panic disorder patients which compared the recommended taper schedule with a slower taper schedule, no difference was observed between the groups in the proportion of patients who tapered to zero dose; however, the slower schedule was associated with a reduction in symptoms associated with a withdrawal syndrome. Dosage Recommendations In Geriatric Patients In geriatric patients, the recommended starting oral dosage of XANAX is 0.25 mg, given 2 or 3 times daily. This may be gradually increased if needed and tolerated. Geriatric patients may be especially sensitive to the effects of benzodiazepines. If adverse reactions occur at the recommended starting dosage, the dosage may be reduced [see Use In Specific Populations, CLINICAL PHARMACOLOGY]. Dosage Recommendations In Patients With Hepatic Impairment In patients with hepatic impairment, the recommended starting oral dosage of XANAX is 0.25 mg, given 2 or 3 times daily. This may be gradually increased if needed and tolerated. If adverse reactions occur at the recommended starting dose, the dosage may be reduced [see Use In Specific Populations, CLINICAL PHARMACOLOGY].
You must be logged in to post a comment.